Public-Private Partnerships Step Up
May 30, 2012
With pharmaceutical R&D efforts in decline, public-private partnerships are emerging as a way to bolster early stage discovery efforts. In Europe, concern over a dwindling antibiotic pipeline led to the European Commission’s Action Plan Against the Rising Threats from Antimicrobial Resistance, launched in November last year (see here).